Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL COMPOSITION FOR THE TREATMENT OF VIRAL INFECTIONS
Document Type and Number:
WIPO Patent Application WO/2021/234554
Kind Code:
A3
Abstract:
The present invention relates to the combination of primary active agent and a mucolytic agent as an adjuvant for the treatment of Viral infections. The present invention relates to the combination of primary active agent and a mucolytic agent as an adjuvant specifically for the treatment of COVID-19. The present invention relates to the co-pack of primary active agent and a mucolytic agent as an adjuvant specifically for the treatment of COVID-19. The present invention specifically relates to composition comprising combination of anti-viral agent as primary active agent and a mucolytic agent as an adjuvant for the treatment of COVID-19. The present invention specifically relates composition comprising combination of anti-gout agent as primary active agent and a mucolytic agent as an adjuvant for the treatment of COVID-19. The present invention more specifically relates to the composition comprising Favipiravir as primary active agent and Carbocisteine as adjuvant, Colchicine as primary active agent and Carbocisteine as adjuvant for the treatment of COVID-19.

Inventors:
BOTHRA CHANDANMAL PUKHRAJ (IN)
BOTHRA HEMANTH KUMAR (IN)
NATARAJAN ELAYARAJA (IN)
AJITHAN VARMA CHITRA (IN)
Application Number:
PCT/IB2021/054246
Publication Date:
January 06, 2022
Filing Date:
May 18, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
LYRUS LIFE SCIENCES PVT LTD (IN)
NOKHA TRADING LLP (IN)
BOTHRA CHANDANMAL PUKHRAJ (IN)
BOTHRA HEMANTH KUMAR (IN)
NATARAJAN ELAYARAJA (IN)
AJITHAN VARMA CHITRA (IN)
International Classes:
A61K31/00; A61P31/14
Domestic Patent References:
WO2017049060A12017-03-23
Foreign References:
CN106309420A2017-01-11
Attorney, Agent or Firm:
SURAPUREDDY, Padmaja (IN)
Download PDF: